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Abstract
Background: Reprogramming adult human somatic cells to create human induced pluripotent stem (hiPS) cell colonies
involves a dramatic morphological and organizational transition. These colonies are morphologically indistinguishable from
those of pluripotent human embryonic stem (hES) cells. G protein-coupled receptors (GPCRs) are required in diverse
developmental processes, but their role in pluripotent colony morphology and organization is unknown. We tested the
hypothesis that Gi-coupled GPCR signaling contributes to the characteristic morphology and organization of human
pluripotent colonies.
Methodology/Principal Findings: Specific and irreversible inhibition of Gi-coupled GPCR signaling by pertussis toxin
markedly altered pluripotent colony morphology. Wild-type hES and hiPS cells formed monolayer colonies, but colonies
treated with pertussis toxin retracted inward, adopting a dense, multi-layered conformation. The treated colonies were
unable to reform after a scratch wound insult, whereas control colonies healed completely within 48 h. In contrast,
activation of an alternative GPCR pathway, Gs-coupled signaling, with cholera toxin did not affect colony morphology or the
healing response. Pertussis toxin did not alter the proliferation, apoptosis or pluripotency of pluripotent stem cells.
Conclusions/Significance: Experiments with pertussis toxin suggest that Gi signaling plays a critical role in the morphology
and organization of pluripotent colonies. These results may be explained by a Gi-mediated density-sensing mechanism that
propels the cells radially outward. GPCRs are a promising target for modulating the formation and organization of hiPS and
hES cell colonies and may be important for understanding somatic cell reprogramming and for engineering pluripotent
stem cells for therapeutic applications.
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Introduction
The ability to reprogram somatic cells back to a pluripotent
state has revolutionized our understanding of developmental
biology [1]. The creation of patient-specific pluripotent stem cells
was a seminal advance toward the use of stem cells for cell-based
therapies and regenerative medicine [2]. During reprogramming,
adult human somatic cells undergo a remarkable transition from
dispersed unicellular fibroblasts to well defined multicellular
colonies of human induced pluripotent stem (hiPS) cells that are
morphologically indistinguishable from human embryonic stem
(hES) cells [2–4] (Figure 1). Both hiPS cells and hES cells self-
renew indefinitely as highly-organized pluripotent colonies that
resemble the inner cell mass from which hES cells are primarily
derived [5,6]. Interestingly, human pluripotent colonies form a flat
uniform monolayer, while mouse pluripotent colonies form
thicker, multilayered colonies [7]. Since pluripotent colony
morphology correlates closely with the maintenance of pluripo-
tency, the mechanisms by which these colonies form and organize
may be important for controlling somatic cell reprogramming.
Understanding these mechanisms may also allow better control of
hiPS cell growth and differentiation ex vivo for therapeutic
applications.
The molecular mechanisms of human pluripotent colony
formation and organization are poorly understood. G protein-
coupled receptors (GPCRs) are attractive candidates as modula-
tors of early developmental processes because they are the largest
class of cell surface receptors, are the targets of small molecule
drugs, and mediate a wide variety of biological processes [8]. Two
of the major G-protein families, Gs and Gi, signal through the
second messenger cyclic AMP. In particular, Gi signaling has
emerged as a conserved developmental regulator of cellular
morphology, polarity, and migration [9–11], including directed
chemotaxis of mouse ES cells [12]. The Agtrl1b-Apelin [13,14],
CXCR4-SDF-1 [15,16] and SPC/S1P-EDG [17,18] pathways
signal using Gi and are key mediators of cellular chemotaxis and
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amoeba Dictyostehm discoidezlm, GCPR signaling regulates the
formation and organization of multi-cellular colonies by mediating
cell-density signaling [19,20]. In adipocytes, Gi-coupled signaling
regulates cell-density dependent proliferation [21,22]. The role of
Gi-coupled signaling in pluripotent stem cells is largely unknown,
but it has been implicated in the maintenance of pluripotency [23]
and directed differentiation [24] of hES cells.
The high number and redundancy among the 370–400
nonordarant GPCRs and G-protein family members poses a
challenge for modulating GPCR signaling pathways experimentally
[25]. To study the role of GPCR signaling in pluripotent colony
morphology and organization, we used bacterial toxins derived
from Bordetella pertussis and Vibrio cholerae, which are global and
irreversible modulators of specific G-protein signaling families.
Pertussis toxin irreversibly uncouples all commonly expressed
members of the Gai gene family (Gai1,G ai2,G ai3,a n dG ao)b y
ADP-ribosylation at a site that blocks interaction with GPCRs,
thereby blocking downstream Gi-coupled GPCR signaling [26–28].
Cholera toxin catalyzes ADP-ribosylation of Gas at a location that
constitutively activates Gas and mimics Gs-coupled GPCR signaling
[20,21].
We hypothesize that hES cell and hiPS cell colonies form and
maintain characteristic pluripotent morphology and organization
through Gi-coupled GPCR signaling. To test this hypothesis, we
treated pluripotent colonies with pertussis toxin or cholera toxin to
irreversibly and specifically modulate Gi or Gs signaling,
respectively, and assessed colony morphology and formation by
time-lapse and confocal microscopy.
Results
Inhibition of Gi Signaling by Pertussis Toxin Prevents
Outgrowth of Pluripotent Stem Cell Colonies
To investigate the role of GPCR signaling in pluripotent colony
morphology, we first determined the effect of blocking Gi signaling
in colonies of hES cell or hiPS cells with pertussis toxin. Colonies
wereculturedonMatrigelwithoutfeeder cells,treatedwith pertussis
toxin or cholera toxin, and imaged by time-lapse phase contrast
microscopy. Within 12 h, pertussis toxin-treated colonies contract-
ed inward, lost pseudopodia-like projections, and adopted a dense,
aggregated morphology similar to that of mouse ES cell colonies
(Figure 2, Supplemental Movie S1). Colonies treated with cholera
toxin to constitutively activate Gs signaling, were not affected by
treatment and, like control colonies, expanded over time.
Figure 1. Morphological change during human somatic cell
reprogramming. Human dermal fibroblasts undergo a dramatic
morphological change during reprogramming and appear to be
identical to a colony of human embryonic stem cells. Scale bar, 200 mm.
doi:10.1371/journal.pone.0007780.g001
Figure 2. Pertussis toxin induces morphological change in human embryonic stem (hES) cells and human induced pluripotent stem
(hiPS) cells. hES cell colony cultured on Matrigel under feeder-free conditions contracts inward, loses pseudopodia-like projections and adopts a
dense, aggregated morphology within 12 h after treatment with pertussis toxin. These alterations were not seen in control colonies or colonies
treated with cholera toxin treated. Red outline delineates the border of the pluripotent colony at the start of toxin treatment, time 0. The area of
colony retraction after 12 h of pertussus toxin treatment is highlighted in red. Scale bar, 200 mm.
doi:10.1371/journal.pone.0007780.g002
Gi-Signaling in hES/hiPS Cells
PLoS ONE | www.plosone.org 2 November 2009 | Volume 4 | Issue 11 | e7780Pluripotent Colonies Require Gi Signaling to Heal a
Scratch Wound Insult
To assess the functional role of GPCR signaling in pluripotent
colony formation and, specifically, to determine if inhibition of Gi
signaling disrupts endogenous organizing mechanisms, we used a
scratch wound healing assay in which colony re-growth into a
denuded area is monitored by time-lapse microscopy (Figure 3A).
As we expected, hES cell or hiPS cell colonies treated with
pertussis toxin were unable to reform after the scratch wound,
whereas control colonies and colonies treated with cholera toxin
healed completely within 48 h (Figure 3B). Wound healing was
also reduced in pluripotent colonies cultured without mouse
embryonic fibroblast (MEF) feeder cells (Figure 3C), suggesting
that feeder cells are not required for the observed phenotype.
Inhibition of Gi Signaling by Pertussis Toxin Disrupts
Pluripotent Colony Organization Independently of
Proliferation, Apoptosis and Pluripotency
To investigate how pertussis toxin inhibited colony wound
healing, we assessed the three-dimensional organization of pertussis
toxin-treated colonies by analyzing Hoechst-stained nuclei by
confocal microscopy. Colonies treated with pertussis toxin under-
went re-organization and were significantly thicker and denser than
control colonies (Figure 4), suggesting that inhibition of Gi signaling
disrupts endogenous mechanisms that maintain human pluripotent
stem cell colonies as characteristic flat monolayers. Nuclear volume
did not differ significantly in treated and control colonies. Identical
results wereobtained inundifferentiated hESand hiPS cell colonies.
Thus, inhibition of Gi signaling with pertussis toxin consistently
changed both the morphology and organization of human
pluripotent colonies resulting in thicker and denser colonies more
closely resemble undifferentiated mouse ES cells.
Next, we determined whether pertussis toxin alters cell
proliferation, apoptosis, or pluripotency, three variables that
would confound interpretation of the morphological and organi-
zational data. No significant differences in proliferation (Figure 5A,
B) or apoptosis (Figure 5C) were observed in treated and control
hES or hiPS cells, as assessed by 5-bromo-29-deoxyuridine (BrdU)
incorporation, cell-cycle modeling and annexin V staining.
Pertussis toxin also did not affect the maintenance of pluripotency
as assessed by the expression of pluripotency markers by
quantitative real-time PCR (Figure 6A) or immunocytochemistry
(Figure 6B). Nor did pertussis toxin affect the ability of colonies to
differentiate into the three embryonic germ layers (Figure 6C) and
develop mature phenotypes, such as rhythmically beating foci
(Supplemental Movie S2). Thus, the effects of pertussis toxin
cannot be explained by increased or decreased colony growth,
viability or pluripotency, but rather represent a disruption in
colony morphology and organization.
hES cell and hiPS Cells Express GPCRs, Including Those of
the Gi Signaling Family
To place our findings in the context of endogenous GPCRs, we
attempted to identify the GPCRs expressed in hES and hiPS cells.
Identifying GPCR transcripts can be difficult because they are
generally expressed at low levels, making DNA microarrays
difficult to interpret. To identify Gi-coupled GPCRs that might
mediate Gi sensitivity in hES cells and hiPS cells, we comprehen-
sively analyzed DNA microarray data for GPCR expression across
many cell types and tissues. We constructed a meta-dataset of hES
and hiPS cells, fibroblasts and 100 somatic normal tissues from
publicly available data from the same DNA-microarray platform
(U133 plus 2.0 array) [3,29]. Comparison of GPCR expression
across tissues yielded a large percentage of GPCRs expressed
above background levels. Expression clustering of all GPCRs
across tissues and cell lines revealed considerable enrichment in
hES and hiPS cells with fibroblasts that were distinct from neural
or other tissue origin (Figure 7).
Included in the list of GPCRs and seven-transmembrane
receptors predicted to be expressed or enriched were those
implicated in embryonic stem cell function, such as CXCR4 [30],
CNR1 [31],VIPR2, FZD5, FZD7, and FZD10 [32]. Filtering
GPCRs by evidence of adenylate cyclase inhibition identified 25
unique GPCRs potentially expressed in pluripotent cells (Table 1).
Although this global analysis only infers expression and does not
provide definitive proof, it suggests that many GPCRs are
expressed in human pluripotent stem cells and provides support
of our initial hypothesis and directions for future study, including
genome-wide sequencing of cellular mRNAs (RNA-seq) and
pharmacological testing of each candidate receptor.
Discussion
This study shows that the colony morphology characteristic of
pluripotent hES and hiPS cells is maintained through a pertussis
toxin-sensitive mechanism downstream of Gi-coupled GPCRs.
Wild-type colonies were discrete and radial with flat, monolayer
organization. Absence of this characteristic morphology and
organization usually suggests a lack or loss of pluripotency in
human pluripotent cell cultures [2,7]. Gi signaling may specifically
mediate the morphology and organization of pluripotent stem cell
colonies by outwardly regulating the density of cells within the
colony. We refer to this as the ‘‘outward model’’ of pluripotent
stem cell organization (Figure 8).
Human pluripotent stem cells organize as a flat monolayer of
cells that tightly adhere to one another. The Rho-Rock-myosin
signaling axis is required to maintain this strong cell-cell adhesion
[33]. Inhibition of Rock renders hES cell colonies more resistant to
enzymatic disassociation [34] and survival as a single-cell
suspension [35]. Although the Rho-Rock-myosin pathway is
known to induce changes in hES cell colony morphology [33],
activation of this pathway is known to be independent of Gi
signaling and is insensitive to pertussis toxin in somatic cells
[36,37]. GPCRs coupled to the G proteins Gq,G 11,G 12, and G13
activate Rho in a pertussis toxin-independent manner [38–40], so
the Rho-Rock-myosin pathway will need to be closely examined as
we extend our studies to these G protein pathways. The exact
molecular mechanism for Gi-induced morphology change is
unknown and there are likely other ways that the GPCR
superfamily could activate changes to cellular morphology. We
anticipate that there will be multiple GPCR pathways that induce
morphology change that work in parallel with the Gi signaling
pathway. The morphology change that we observe with pertussis
toxin is also likely to alter the expression and function of adhesion
molecules such as E-cadherin, a key regulator of ES cell adhesion
[41]. Unfortunately, we do not at this time have a complete
annotation of all cell surface adhesion molecules involved in this
process. These genes are often expressed at low levels where DNA
microarray data is not accurate. We are currently embarking on
deep sequencing of hES and hiPS cells to gain a more robust list of
the cell surface molecules that can be probed for involvement in
human pluripotent cell morphology.
Our findings indicate that Gi signaling orchestrates the
organization of human pluripotent stem cell colonies as an
interconnected monolayer of cells. Gi signaling may maintain
pluripotent stem cell colony morphology by outwardly organizing
cells much like the springs anchoring the stretched fabric of a
Gi-Signaling in hES/hiPS Cells
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colonies. (A) Time-lapse series shows that pertussis toxin, but not cholera toxin, attenuates pluripotent colony wound healing. Scale bar, 200 mm. (B
and C) hES and hiPS cell colonies grown in the presence (B) or absence (C) MEF feeder cell lines exhibit significant reductions in colony wound
healing after treatment with pertussis toxin, alone or together with cholera toxin, but not cholera toxin alone. Values are percent area healed relative
to healing in control colonies. Error bars indicate the standard deviation. * P , 0.05.
doi:10.1371/journal.pone.0007780.g003
Gi-Signaling in hES/hiPS Cells
PLoS ONE | www.plosone.org 4 November 2009 | Volume 4 | Issue 11 | e7780trampoline (Figure 8). The remarkable wound healing exhibited
by wild-type pluripotent colonies suggests that colonies can detect
the wounded area and actively reform to maintain colony
integrity. Disrupting Gi signaling with pertussis toxin blocks the
outward forces so that the colonies cannot re-enter the denuded
area of the scratch assay, thereby inducing a morphological and
organizational change.
Inhibition of Gi signaling with pertussis toxin converted the
monolayer colony characteristic of wild-type pluripotent cells into
a multilayered colony. The monolayer colony is a hallmark of
human pluripotent cells, first described for hES cells [5] and later
for hiPS cells [2]. These results suggest that a Gi-coupled receptor
actively participates in maintaining the morphology of human
pluripotent colonies. Characteristic colony morphology serves as
an important initial screen during the production of hiPS cells
[2,7]. Insights into how the morphology and organization of
pluripotent colonies are regulated will thus be important to
understanding the molecular mechanisms of somatic cell repro-
gramming. We hypothesize that similar Gi-coupled GPCRs are
involved in pluripotent colony formation and maintenance during
iPS cell induction. These mediators of iPS cells formation may
provide clues to identify factors important for the production of
hiPS cells free of genetic modification.
Gi signaling may also play a role in the long observed difference
between mouse and human pluripotent colonies. In contrast to
monolayer human ES colonies, mouse ES cells form multilayered
colonies that are clearly pluripotent as they satisfy the most stringent
criteria for pluripotency including tetraploid complementation [42].
In view of the significant differences in colony morphology, some
investigators have wondered whether human ES cells are truly as
pluripotent as mouse ES cells. Interestingly, mouse ES cells treated
with pertussus toxin exhibit a phenotype that is similar to that in
hES and hiPS cells but attenuated (data not shown). The mouse cell
phenotype may be harder to elicit because they are already
retracted in their basal state. This suggests that mouse and human
pluripotent stem cell colonies share a common Gi-mediated
mechanism for colony organization. The difference in wild-type
colony morphology between mouse and human pluripotent cells
may reflect differential amounts of Gi-coupled GPCR signaling in
pluripotent colonies. This hypothesis can be tested in future studies
by directly stimulating Gi-coupled GPCRs in mouse and human ES
cells using engineered receptors such as RASSLs (receptor activated
solely by a synthetic ligand) [43].
Byanalyzingalargetissueandcelllinemeta-dataset,weidentified
GPCRs, includingGi-coupled receptors,withevidenceof expression
in human pluripotent stem cells. Such an analysis has several
drawbacks over more quantitative measures (e.g., transcript
sequencing, protein detection), but nevertheless provides a prelim-
inary candidate list for identifying mediators of the Gi sensitivity of
hESandhiPScells.Manipulatingtheprocessesbywhichpluripotent
colonies form and organize may also be critical for therapeutic
applications. As hiPS cell technology matures as a viable source for
cell-based therapeutics and regenerative medicine, controlling the
multi-cellular morphological and organizational characteristics of
pluripotent stem cells ex vivo will become increasingly important.
GPCRs and their downstream signaling pathways are attractive
targets for study in human pluripotent stem cells.
Materials and Methods
Cell Culture
Pluripotent hES cells (H9, WiCell) with fewer than 50 passages
and hiPS cells derived from adult human dermal fibroblasts (Cell
Applications) were generated as described [2]. Undifferentiated
hES cells were cultured as described [2,44] with minor
modifications. Briefly, cells were cultured in knockout Dulbecco’s
modified Eagle’s medium/F-12 (Invitrogen, Carlsbad, CA)
supplemented with 1 mM L-glutamine, 20% knockout serum
replacement medium (Invitrogen), 1 mM sodium pyruvate
(Invitorgen), 0.1 mM nonessential amino acids (NEAA, Invitro-
Figure 4. Disrupted pluripotent stem cell colony organization by pertussis toxin in human embryonic stem (hES) cells and human
induced pluripotent stem (hiPS) cells. Three dimensional confocal projections of pluripotent colonies treated with pertussis toxin and stained
with Hoechst show increased colony thickness and density, but no significant change in nuclear volume. Pluripotent stem cells treated with pertussis
toxin aggregate and stack three dimensionally whereas control colonies maintain a monolayer conformation. Error bars indicate the minimum and
maximum data points. Scale bar, 100 mm. * P , 0.05. NS=Not significant.
doi:10.1371/journal.pone.0007780.g004
Gi-Signaling in hES/hiPS Cells
PLoS ONE | www.plosone.org 5 November 2009 | Volume 4 | Issue 11 | e7780gen), 0.5% penicillin and streptomycin (UCSF Cell Culture
Facility), 0.1 mM beta-mercaptoethanol (Sigma), and 10 ng/ml
full-length basic fibroblast growth factor (Invitorgen). Cells were
grown in MEF-conditioned medium in six-well plates (Corning,
catalog no. 3506) coated with growth factor-reduced Matrigel (BD
Bioscience) with MEF-conditioned medium or on a feeder layer of
irradiated SNL MEFs [45]. Matrigel was prepared in cold
Knockout DMEM at 1:100 dilution and allowed to coat the
culture plates for at least 45 min at room temperature. Excess
Matrigel was removed, and the plates were washed once with
Dulbecco’s phosphate-buffered saline (DPBS) immediately before
plating of cells. SNL MEFs were gamma-irradiated with 3000 rads
(30 Grays) and plated at 10
4 cells per cm
2. All cells were passaged
after enzymatic digestion with Accutase (Millipore) approximately
every 7 days as described [46]. For passage, cells were washed
twice with DPBS and treated with a minimal amount of Accutase
for 1 min at room temperature. Accutase was removed, and the
culture was gently washed twice with DPBS (Ca
2+- and Mg
2+-free).
Cells were harvested by gentle cell scraping and split at a ratio of
1:4 to 1:6 and cultured for 24 h with 10 mM ROCK inhibitor (Y-
27632, Calbiochem) as described [34]. Cells were routinely tested
for mycoplasma (Mycoplasma Plus PCR Primer Set, Stratagene).
Toxin Treatment
Pertussis toxin from Bordetella pertussis (Sigma) was prepared in
water with 2.5 mg/ml bovine serum albumin (BSA) (Sigma) to a
stock concentration of 50 mg/ml. Cholera toxin from Vibrio cholerae
Figure 5. Proliferation and apoptosis are unchanged by pertussis toxin treatment in human embryonic stem (hES) cells and human
induced pluripotent stem (hiPS) cells. (A) Pluripotent hES cell and hiPS cells colonies were treated with pertussis toxin or control medium and
pulsed with BrdU for 2 h to detect proliferating cells. Representative flow cytometery data show no difference in BrdU incorporation between
treatments: 48.0% of pertussis toxin-treated hES cells were BrdU positive vs. 50.3% of control cells. (B) Pluripotent hES cell and hiPS cells colonies
were treated with pertussis toxin or control medium and stained with propidium iodide to model cell-cycle states. Representative flow cytometery
histograms show no difference in number of cells in G2-M, G0-G1, or S phase between treatments. (C) To assess whether pertussis toxin affects
apoptosis of pluripotent stem cells, colonies treated with pertussis toxin or control medium were stained with Annexin V, a marker of apoptosis, and
analyzed by flow cytometry. Pluripotent hES cell and hiPS cells colonies were treated with either pertussis toxin, control or the pro-apoptotic agent
camptothecin and stained with annexin V and propidium iodide. Representative flow cytometery data show no difference in BrdU incorporation
between pertussis toxin and control treatments. Camptothecin induced apoptosis in 34.0% of pertussis toxin-treated cells and 32.7% of control cells.
doi:10.1371/journal.pone.0007780.g005
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ml. Pluripotent stem cells were treated with pertussis toxin (final
concentration, 200 ng/ml) or cholera toxin at the final concen-
tration of 10 mg/ml for 2 h in Knockout DMEM/F-12 medium
supplemented with 0.25% BSA, 1 mM L-glutamine, 1 mM
sodium pyruvate, 0.1 mM NEAA, 0.5% penicillin and strepto-
mycin, and 0.1 mM beta-mercaptoethanol, followed by 1:1
addition of pluripotent stem cell culture medium containing
20% Knockout Serum Replacement medium for 12 h. Controls
were treated in the same fashion except that water containing
2.5 mg/ml BSA was used instead of toxin. The medium was
changed daily with human pluripotent medium described
previously and maintained under standard pluripotent conditions
throughout the assay.
Time-Lapse Microscopy
Control and pertussis toxin-treated colonies were imaged with a
Carl Zeiss Axio Observer Z1 and AxioVision version 4.7 software
(Carl Zeiss) and configured with a linearly scaled stage and an XL
S incubation unit (Carl Zeiss) to maintain physiological atmo-
spheric conditions at 37uC and 5% CO2 with humidification.
Time-lapse images were captured with an EC Plan-Neofluar 56/
0.16 M27 objective with 1.6 Optivar (Carl Zeiss) every 5 or
10 min and exported to Adobe Premiere CS3 software for
compilation, analysis and video output.
Scratch Wound Healing Assay
Pluripotent hES and hiPS cells were cultured as discrete
colonies to 50–75% confluency and treated with control medium,
pertussis toxin, or cholera toxin as described above. A linear
scratch wound was placed across the culture with a 200 ml LTS
pipette tip (Rainin) and washed once with Knockout DMEM/F12
to remove debris. The scratched cultures were serially imaged by
phase-contrast microscopy or prepared for time-lapse imaging and
cultured in pluripotent stem cell culture medium for the duration
of the assay. Analysis was performed with Adobe Photoshop CS3
by manually masking the boundaries of the scratched area and
quantifying the area of colony healing over time using the
Photoshop Extended Measurement feature. Data are reported as
the percentage of healed area relative to that in control colonies.
This assay assumes that proliferation and apoptosis are unchanged
by the treatment parameters. Thus, controlling for these potential
confounders is important to validate any results.
Confocal Microscopy
Control and pertussis toxin-treated colonies were fixed with 4%
paraformaldehyde for 15 min, stained with Hoechst stain (Invitro-
gen; 1:2000) for 10 min, washed twice with DPBS, and immediately
imaged on a Carl Zeiss LSM510 Meta Confocal Microscope with a
Plan-Neofluar 256/0.8 multi-immersion objective (Carl Zeiss).
Confocal projections were compiled with MetaMorph version 5
(Molecular Devices) and Zen LE (Carl Zeiss) software. Colony
thickness was measured on confocal projections with MetaMorph.
Automated nuclei counting of confocal images was performed with
ImageJ (http://rsbweb.nih.gov/ij) using a modification of the 3D
Object Counter plugin (http://rsbweb.nih.gov/ij/plugins/track/
objects.html; script available upon request). Nucleic volume was
calculated with ImageJ and a modification of Voxel Counter plugin
(http://rsbweb.nih.gov/ij/plugins/voxel-counter.html; script avail-
able upon request).
Proliferation Assay
Colonies maintained on Matrigel and MEF-conditioned
medium were treated with control medium or pertussis toxin,
Figure 6. Pertussis toxin does not affect the maintenance of pluripotency pluripotent stem cell colonies or the ability to form all
three embryonic germ layers. (A) Pertussis toxin does not affect the maintenance of pluripotency of hES or hiPS cells as assessed by the
expression of the pluripotency markers Nanog, Oct4, Sox2, TDGF1, and ZFP42 by quantitative real-time PCR. (B) Immunocytochemistry of TRA-1-81
(green) and Oct-3/4 (red) also did not reveal differences between hES or hiPS cells treated with pertussis toxin and control treatments in pluripotent
stem cell colonies. Nuclei were stained with Hoechst (blue). Scale bar, 200 mm. (C) hES or iPS cells treated with pertussis toxin formed embryoid
bodies and differentiated into cell types of the all three embryonic germ layers as assessed by immunocytochemistry for a-fetoprotein (a marker of
endoderm), a-smooth muscle actin (mesoderm) and bIII-tubulin (ectoderm). Scale bar, 100 mm.
doi:10.1371/journal.pone.0007780.g006
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pulsed with 100 mM BrdU for 2 h. Cells were cultured for an
additional 12 h in pluripotent conditions and harvested with
Accutase as described above, mechanically dispersed to a single-
cell suspension, and washed by repeated centrifugation. Cells were
fixed with 70% ethanol and stored at 220uC until further
processing. Cells were pelleted and washed twice with wash buffer
(10 mM HEPES, pH 7.4, 150 mM NaCl, 4% FBS) and incubated
in 0.5 ml of 2 M HCl +0.5% FBS for 20 min at room
temperature. Cells were washed again in wash buffer, pelleted,
and resuspended in 100 mM sodium tetraborate (Sigma) for 2 min
at room temperature. Cells were again washed with wash buffer
and stained with anti-BrdU-Alexa 488 flourphore prepared 1:1000
in DPBS and incubated for 30 min at room temperature. Stained
cells were washed twice with wash buffer, pelleted, and co-stained
with 10 mg/ml propidium iodide with 1 mg/ml RNase A in DPBS
for 30 min at room temperature. Stained cells were filtered and
counted on a FACSCalibur flow cytometer (BD Biosciences) and
analyzed by FlowJo software (Tree Star). DNA distributions were
analyzed with ModFit (Verity Software House) to determine the
proportions of pluripotent stem cells in G0-G1, S, and G2-M
phases of the cell cycle.
Apoptosis Assay
Colonies maintained on Matrigel and MEF-conditioned
medium were treated with control medium or pertussis toxin as
described above and cultured in pluripotent conditions for 24 h.
Camptothecin (Sigma), a pro-apoptotic agent, was used as a
positive control at 5 mM in DMSO and incubated for 5 h. Cells
(5610
5) were harvested as described above and mechanically
dispersed to a single-cell suspension by trituration. Cells were
stained with the Annexin V-FITC apoptosis detection kit (BD
Pharmingen) according to the manufacturer’s protocol with minor
modifications. Briefly, cells were resuspended in binding buffer at
1610
6 cells/ml and stained with Annexin V and propridium
iodide for 15 min, diluted 1:1 with binding buffer, filtered, and
Figure 7. Gene expression clustering reveals enrichment of GPCRs in stem cells. A heat-map of microarray probesets aligning to predicted
GPCRs across 100 somatic tissues and cell types, hES cells and hiPS cells. Relative expression differences were calculated relative to the mean
expression of all tissues and cells for each probeset. The mean expression values of specific tissue groups (e.g., cardiovascular) were grouped to
highlight the relative expression differences compared to hES cell and hiPS cells. Expression patterns reveal clustering of GPCRs according to
pluripotent/fibroblast, neural or multi-tissue origin.
doi:10.1371/journal.pone.0007780.g007
Table 1. 25 Gi-coupled GPCRs are potentially expressed in pluripotent cells.
Symbol Description iPS/ES p-value iPS/ES fold difference GPCR-coupling
ADORA3 adenosine A3 receptor 8.40E-06 21.84 Gi
ADRA2A adrenergic, alpha-2A-, receptor 5.37E-05 2.82 Gi
ADRA2C adrenergic, alpha-2C-, receptor 2.18E-06 1.37 Gi
CNR1 cannabinoid receptor 1 (brain) 9.54E-05 2.71 Gi
CNR2 cannabinoid receptor 2 (macrophage) 1.20E-02 21.20 Gi
CXCR4 chemokine (C-X-C motif) receptor 4 8.05E-03 1.72 Gi
DRD3 dopamine receptor D3 1.32E-06 1.20 Gi
DRD4 dopamine receptor D4 1.27E-06 2.08 Gi
EDG2 endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 4.72E-03 2.05 Go,Gq,G13,G12,Gi
EDG4 endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 4 1.96E-08 2.28 Go,Gq,G13,G12,Gi
EDG7 endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7 9.33E-11 2.45 Go,Gq,Gi
EDG8 endothelial differentiation, sphingolipid G-protein-coupled receptor, 8 3.70E-08 1.86 G12,Gi
FFAR2 free fatty acid receptor 2 1.56E-03 1.25 Gq,Gi
FFAR3 free fatty acid receptor 3 6.40E-05 1.37 Gq,Gi
GABBR1 gamma-aminobutyric acid (GABA) B receptor, 1 5.96E-05 1.74 Gq,Gi
GABBR2 gamma-aminobutyric acid (GABA) B receptor, 2 9.77E-06 4.58 Gq,Gi
GALR2 galanin receptor 2 4.71E-07 1.72 Gq,Gi
GRM2 glutamate receptor, metabotropic 2 7.85E-08 1.73 Gi
GRM4 glutamate receptor, metabotropic 4 1.13E-02 1.21 Gi
HTR1B 5-hydroxytryptamine (serotonin) receptor 1B 1.78E-03 1.22 Gi
HTR1D 5-hydroxytryptamine (serotonin) receptor 1D 1.07E-03 1.83 Gi
MCHR1 melanin-concentrating hormone receptor 1 1.36E-04 1.49 Gq,Gi
NPY5R neuropeptide Y receptor Y5 1.47E-04 1.41 Gi
OXER1 oxoeicosanoid (OXE) receptor 1 1.98E-04 21.23 Go,Gi
P2RY13 purinergic receptor P2Y, G-protein coupled, 13 2.06E-04 21.36 Gi
The GPCRs were identified by filtering the microarray dataset (Supplemental Dataset S1) for Gi-coupled GPCRs likely expressed in hES or hiPS cells (p-value , 0.05 and
mean fold difference $2).
doi:10.1371/journal.pone.0007780.t001
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were analyzed with FlowJo software version 8.8.6.
Targeted Gene Expression Assay
ES cells or EBs were harvested in Trizol (Invitrogen) for total
RNA isolation. For mRNA qRT-PCR, 2 mg of total RNA from
each sample was reversed transcribed with Superscript III
(Invitrogen). cDNA (10 ng) was used for subsequent PCRs,
performed in triplicate on an ABI 7900HT instrument (Applied
Biosystems) using Taqman primer probe sets (Applied Biosystems)
for each gene of interest and a GAPDH endogenous control
primer probe set for normalization. Each qRT-PCR was
performed on three different experimental samples; representative
results are shown as fold expression relative to undifferentiated and
control hES cells. Error bars reflect one standard deviation from
the mean of technical replicates.
hES Cell and hiPS Cell Differentiation
hES cell and hiPS cells were grown to near confluency.
Differentiation was performed as described [44]. Briefly,
differentiation was initiated by embryoid body (EB) formation
on day 0 by treatment with 1 mg/ml collagenase IV followed by
two rinses with DPBS to remove any residual MEFs. The
collagenase IV-treated colonies were dispersed by gentle
mechanical pipette trituration into cell aggregates of 500–800
cells in differentiation medium (Knockout DMEM/F-12 supple-
mented with 20% fetal bovine serum (FBS; Hyclone), 1 mM L-
glutamine, 1 mM sodium pyruvate, 0.1 mM NEAA, 50 U/ml
penicillin, 50 mg/ml streptomycin, and 0.1 mM beta-mercap-
toethanol). Aggregates were immediately re-plated on low
attachment plates (Corning). The medium was replaced with
fresh medium once on day 4, and the EBs were transferred onto
0.1% gelatin-coated 10 cm
2 culture dishes and followed for up to
24 additional days; half the medium was replaced with fresh
medium every other day.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde in PBS for 10 min
at room temperature, washed with PBS, and washed twice in 0.1%
Triton X-100 (Sigma) in PBS. Cells were blocked with 5% normal
goat serum (Sigma) in PBS containing 0.1% Triton X-100 for 1 h
at room temperature. The primary antibodies were Oct-3/4
(1:1000, MAB1759, R&D Systems), TRA-1-81 (1:50, MAB4381,
Chemicon), a-fetoprotein (1:100, MAB1368, R&D Systems), a-
smooth muscle actin (prediluted, DAKO), and bIII-tubulin (1:100,
CB412, Chemicon). The secondary antibodies were cyanine 3
(Cy3) -conjugated goat anti-rat IgM (1:500, Jackson Immunor-
esearch), Alexa555-conjugated goat anti-mouse IgG (1:500,
Invitrogen), Alexa555-conjugated goat anti-mouse IgM (1:500,
Invitrogen), and Alexa488-conjugated goat anti-mouse IgM
(1:500, Invitrogen). Nuclei were stained with 1 mg/ml Hoechst
33342 (Invitrogen). Stained cells were imaged by epiflourescence
on a Zeiss AxioObserver with LD Plan-Neofluar 206/0.4 Korr
objective and AxioVision software. Images were exported to
Adobe Photoshop CS3 for compilation.
Statistical Analysis
All experiments were performed a minimum of three times.
Two-sample t tests (equal variance) were used to analyze the
significance of difference for apoptosis assays. P , 0.05 was
considered statistically significant. Standard deviations were
calculated for the scratch wound healing, Annexin V, and BrdU
incorporation assays.
Gene Expression Microarray Analysis
For the microarray meta-dataset analysis, all Affymetrix CEL
files were downloaded from NCBI Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo) for the U133 plus 2.0 array
platform from published datasets. This dataset consisted of normal
adult human tissue samples from the human body index
compendium study (GSE7307), hES cells, hiPS cells, and
fibroblast lines (GSE9709 and GSE9832) [3,29]. For all datasets,
one to three arbitrary biological replicates per tissue were used
(based on availability). All data was co-normalized in the program
AltAnalyze [47] with the RMA algorithm, producing mean
expression values for each group of biological replicates.
GPCR Annotations
Probesets from this dataset were linked to GPCR annotations
and phenotypes from UniProt and the Mouse Genome Informat-
ics databases, respectively, using a custom Python script. To
produce GPCR coupling annotations, this script uses a custom
heuristic to identify the G-protein alpha protein sub-type (Gai,
Gaq,G as,G a11,G a12,G a13,G a olf,G a taste), based on the UniProt
curated description field (script available upon request).
Determining Expression of GPCRs
To predict whether GPCRs in hES or hiPS cells are expressed,
sufficiently above background we compared expression in these
cells to other tissues. Typically Affymetrix Absent-Present (AP)
calls are sufficient to identify GPCRs that are predicted to be
expressed. However, since AP calls varied considerable variability
between replicates (data not shown), we used an alternative
method. Each hiPS cell and hES cell line was compared to the 10
lowest expressing tissues/cell lines (excluding hiPS cell and hES
cell). All fibroblast cell lines were combined into a single group. A t
test was performed on the 10 lowest expressing tissues for each
GPCR relative to the combined hiPS cell and hES cell lines.
GPCRs with a p-value , 0.05 and a mean fold change $1.5 were
Figure 8. Model of organization of pluripotent stem cell
colonies. Gi signaling may control pluripotent stem cell morphology
and organization through density-sensing that outwardly organizes
pluripotent stem cell colonies in a homogenous monolayer. Disruption
of Gi signaling with pertussis toxin results in colonies that are
contracted inward, densely aggregated and stacked. An alternative
model in which Gi signaling mediates inward organization of
pluripotent stem cells was not supported by the data.
doi:10.1371/journal.pone.0007780.g008
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performed for all tissues and cell lines using the program
HOPACH (hierarchical ordered partitioning and collapsing
hybrid), with uncentered correlation distance, relative to the mean
expression of all tissues and cells [48,49]. All data from this
analysis are provided as supplemental data (Supplemental Dataset
S1 and Supplemental Dataset S2).
Supporting Information
Movie S1 Time-lapse movie of colony morphology rearrange-
ment by pertussis toxin in human embryonic stem (hES) cells. A
hES cell colony cultured on Matrigel under feeder-free conditions
contracts inward, loses pseudopodia-like projections and adopts a
dense, aggregated morphology within 12 h after pertussis toxin
treatment. Colonies were treated with control medium or cholera
toxin formed monolayers. Identical observations were made in
human induced pluripotent stem (hiPS) cells. Movie frames were
captured at 5 min intervals. Scale bar, 200 mm.
Found at: doi:10.1371/journal.pone.0007780.s001 (0.90 MB
MOV)
Movie S2 Time-lapse movie of beating colonies formed by both
control and pertussis toxin-treated human induced pluripotent
stem (hiPS) cell colonies. Treatment with pertussis toxin did not
affect differentiation of hiPS cells into embryoid bodies to yield
beating foci. Efficiencies of deriving beating foci were similar
between treatments. Identical observations were made in human
embryonic stem (hES) cells. Video was captured in real-time. Scale
bar, 200 mm.
Found at: doi:10.1371/journal.pone.0007780.s002 (0.72 MB
MOV)
Dataset S1 Excel worksheet of microarray analyses.
Found at: doi:10.1371/journal.pone.0007780.s003 (0.17 MB
XLS)
Dataset S2 Raw dataset used to perform microarray analyses.
Found at: doi:10.1371/journal.pone.0007780.s004 (1.56 MB
XLS)
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